2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Gordon Carl L | — | 5,826,224 | Feb 10, 2021 |
| Atlas Venture Fund XII, L.P. | — | 5,254,365 | Feb 11, 2021 |
| Atlas Venture Associates XII, L.P. | — | 5,254,365 | Feb 11, 2021 |
| Atlas Venture Associates XII, LLC | — | 5,254,365 | Feb 11, 2021 |
| Rhodes Jason P | — | 5,254,365 | Feb 11, 2021 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4, 2026 | Savage William Jacob | Chief Medical Officer | Sell | 28.8 | -7,378 | -7.97% | ✓ | $486.1K |
| Feb 25, 2026 | Feb 27, 2026 | Franchi Jean M. | CFO | Sell | 51.9 | -353 | -0.49% | ✓ | $24.4K |
| Feb 17, 2026 | Feb 19, 2026 | Franchi Jean M. | CFO | Sell | 25.0 | -11,156 | -13.52% | ✓ | $719.7K |
| Feb 17, 2026 | Feb 17, 2026 | Khara Rahul | Chief Legal Officer | Sell | 42.5 | -2,853 | -5.18% | ✗ | $179.3K |
| Feb 17, 2026 | Feb 17, 2026 | Stephenson Pamela | Chief Commercial Officer | Sell | 40.0 | -5,531 | -6.39% | ✗ | $347.7K |
| Feb 17, 2026 | Feb 17, 2026 | Savage William Jacob | Chief Medical Officer | Sell | 42.5 | -3,256 | -3.40% | ✗ | $204.7K |
| Feb 17, 2026 | Feb 17, 2026 | Yu Jonathan Yen-Wen | COO | Sell | 42.5 | -3,231 | -5.61% | ✗ | $203.1K |
| Feb 17, 2026 | Feb 17, 2026 | Quisel John D | CEO | Sell | 40.0 | -13,264 | -5.54% | ✗ | $833.8K |
| Feb 10, 2026 | Feb 11, 2026 | Khara Rahul | Chief Legal Officer | Neutral | 90.0 | +17,000 | 44.71% | ✗ | - |
| Feb 10, 2026 | Feb 11, 2026 | Stephenson Pamela | Chief Commercial Officer | Neutral | 90.0 | +17,000 | 24.45% | ✗ | - |
| Feb 10, 2026 | Feb 11, 2026 | Savage William Jacob | Chief Medical Officer | Neutral | 90.0 | +17,000 | 21.56% | ✗ | - |
| Feb 10, 2026 | Feb 11, 2026 | Yu Jonathan Yen-Wen | COO | Neutral | 90.0 | +17,000 | 41.92% | ✗ | - |
| Feb 10, 2026 | Feb 11, 2026 | Franchi Jean M. | CFO | Neutral | 90.0 | +19,000 | 29.92% | ✗ | - |
| Feb 10, 2026 | Feb 11, 2026 | Quisel John D | CEO | Neutral | 90.0 | +55,200 | 29.98% | ✗ | - |
| Jan 20, 2026 | Jan 21, 2026 | Khara Rahul | Chief Legal Officer | Sell | 42.5 | -1,000 | -2.58% | ✓ | $69.7K |
| Jan 2, 2026 | Jan 5, 2026 | Khara Rahul | Chief Legal Officer | Sell | 25.0 | -6,500 | -14.68% | ✓ | $511.5K |
| Dec 22, 2025 | Dec 29, 2025 | Savage William Jacob | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 19, 2025 | Quisel John D | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 17, 2025 | Dec 18, 2025 | Bitterman Kevin | Director | Sell | 47.5 | -754 | -0.11% | ✗ | $69K |
| Dec 12, 2025 | Dec 16, 2025 | Bitterman Kevin | Director | Sell | 15.0 | -184,123 | -3.72% | ✗ | $16.9M |
| Dec 15, 2025 | Dec 16, 2025 | Savage William Jacob | Chief Medical Officer | Sell | 20.0 | -13,093 | -14.75% | ✓ | $1.2M |
| Dec 11, 2025 | Dec 15, 2025 | Quisel John D | CEO | Sell | 15.0 | -40,000 | -18.88% | ✓ | $3.7M |
| Nov 11, 2025 | Nov 13, 2025 | Yu Jonathan Yen-Wen | COO | Sell | 5.0 | -30,000 | -42.52% | ✓ | $2.5M |
| Oct 22, 2025 | Oct 24, 2025 | AI DMI LLC | 10% Owner | Sell | 15.0 | -744,047 | -20.91% | ✗ | $59.9M |
| Oct 15, 2025 | Oct 17, 2025 | Bitterman Kevin | Director | Sell | 16.3 | -93,585 | -1.24% | ✗ | $8M |
| Oct 7, 2025 | Oct 9, 2025 | Bitterman Kevin | Director | Sell | 16.3 | -90,000 | -15.24% | ✗ | $6.3M |
| Sep 16, 2025 | Sep 18, 2025 | GEMAYEL GEORGES | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 9, 2025 | Sep 11, 2025 | Quisel John D | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 22, 2025 | Aug 26, 2025 | Bitterman Kevin | Director | Sell | 48.8 | -2,287 | -0.39% | ✓ | $139.6K |
| Aug 13, 2025 | Aug 15, 2025 | Bitterman Kevin | Director | Sell | 27.5 | -32,174 | -5.15% | ✓ | $2M |
| Aug 5, 2025 | Aug 7, 2025 | Bitterman Kevin | Director | Sell | 55.0 | -395 | -0.06% | ✓ | $24.1K |
| Jul 30, 2025 | Aug 1, 2025 | Bitterman Kevin | Director | Sell | 42.5 | -8,492 | -1.34% | ✓ | $518.4K |
| Jul 23, 2025 | Jul 25, 2025 | Bitterman Kevin | Director | Sell | 17.5 | -42,870 | -6.33% | ✗ | $2.6M |
| Jul 18, 2025 | Jul 22, 2025 | Bitterman Kevin | Director | Sell | 51.3 | -664 | -0.10% | ✗ | $40.6K |
| Jul 17, 2025 | Jul 18, 2025 | Franchi Jean M. | CFO | Sell | 37.5 | -2,031 | -3.10% | ✓ | $119.8K |
| Jul 14, 2025 | Jul 16, 2025 | AHMED NADIM | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 16, 2025 | AHMED NADIM | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 10, 2025 | Jul 14, 2025 | Franchi Jean M. | CFO | Sell | 41.3 | -2,000 | -2.96% | ✓ | $115K |
| Jul 9, 2025 | Jul 11, 2025 | Quisel John D | CEO | Sell | 15.0 | -34,800 | -17.70% | ✓ | $1.9M |
| Jul 3, 2025 | Jul 8, 2025 | Quisel John D | CEO | Sell | 35.0 | -5,200 | -3.11% | ✓ | $286.5K |
| Jun 27, 2025 | Jul 1, 2025 | Savage William Jacob | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2025 | Jun 18, 2025 | Franchi Jean M. | CFO | Sell | 41.3 | -2,000 | -2.88% | ✓ | $104.5K |
| Jun 11, 2025 | Jun 13, 2025 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Ratcliffe Liam | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Nicholson Donald William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | GEMAYEL GEORGES | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Chin Mark | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Bitterman Kevin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Ashiya Mona | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 6, 2025 | Jun 9, 2025 | Savage William Jacob | Chief Medical Officer | Sell | 32.5 | -2,996 | -5.02% | ✓ | $149.8K |
| May 20, 2025 | May 22, 2025 | Savage William Jacob | Chief Medical Officer | Sell | 22.5 | -6,677 | -10.06% | ✓ | $334.1K |
| May 2, 2025 | May 6, 2025 | Savage William Jacob | Chief Medical Officer | Sell | 37.5 | -2,100 | -3.07% | ✓ | $105.4K |
| Apr 7, 2025 | Apr 8, 2025 | Quisel John D | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 24, 2025 | Mar 26, 2025 | Ashiya Mona | Director | Sell | 37.5 | -5,738 | -0.40% | ✗ | $310.5K |
| Mar 24, 2025 | Mar 26, 2025 | ORBIMED ADVISORS LLC | Director | Sell | 37.5 | -5,738 | -0.40% | ✗ | $310.5K |
| Mar 19, 2025 | Mar 21, 2025 | Ashiya Mona | Director | Sell | 17.5 | -52,429 | -1.21% | ✗ | $2.8M |
| Mar 19, 2025 | Mar 21, 2025 | ORBIMED ADVISORS LLC | Director | Sell | 17.5 | -52,429 | -1.21% | ✗ | $2.8M |
| Mar 10, 2025 | Mar 12, 2025 | Ashiya Mona | Director | Sell | 15.0 | -312,384 | -3.87% | ✗ | $17M |
| Mar 10, 2025 | Mar 12, 2025 | ORBIMED ADVISORS LLC | Director | Sell | 15.0 | -312,384 | -3.87% | ✗ | $17M |
| Feb 18, 2025 | Feb 20, 2025 | Stephenson Pamela | Chief Commercial Officer | Sell | 42.5 | -3,137 | -4.32% | ✗ | $171.2K |
| Feb 18, 2025 | Feb 20, 2025 | Khara Rahul | Chief Legal Officer | Sell | 42.5 | -1,161 | -3.00% | ✗ | $63.4K |
| Feb 18, 2025 | Feb 20, 2025 | Savage William Jacob | Chief Medical Officer | Sell | 42.5 | -1,638 | -2.34% | ✗ | $89.4K |
| Feb 18, 2025 | Feb 20, 2025 | Yu Jonathan Yen-Wen | COO | Sell | 42.5 | -1,610 | -3.82% | ✗ | $87.9K |
| Feb 18, 2025 | Feb 20, 2025 | Franchi Jean M. | CFO | Sell | 42.5 | -3,136 | -4.32% | ✗ | $171.2K |
| Feb 18, 2025 | Feb 20, 2025 | Quisel John D | CEO | Sell | 40.0 | -5,574 | -3.48% | ✗ | $304.2K |
| Feb 10, 2025 | Feb 12, 2025 | Stephenson Pamela | Chief Commercial Officer | Neutral | 90.0 | +36,000 | 98.18% | ✗ | - |
| Feb 10, 2025 | Feb 12, 2025 | Khara Rahul | Chief Legal Officer | Neutral | 90.0 | +24,000 | 171.00% | ✗ | - |
| Feb 10, 2025 | Feb 12, 2025 | Yu Jonathan Yen-Wen | COO | Neutral | 90.0 | +24,000 | 132.12% | ✗ | - |
| Feb 10, 2025 | Feb 12, 2025 | Franchi Jean M. | CFO | Neutral | 90.0 | +36,000 | 98.18% | ✗ | - |
| Feb 10, 2025 | Feb 12, 2025 | Quisel John D | CEO | Neutral | 90.0 | +78,337 | 95.46% | ✗ | - |
| Feb 3, 2025 | Feb 12, 2025 | Savage William Jacob | Chief Medical Officer | Neutral | 90.0 | +24,000 | 52.02% | ✗ | - |
| Feb 3, 2025 | Feb 4, 2025 | Khara Rahul | Chief Legal Officer | Sell | 7.5 | -7,500 | -34.83% | ✓ | $416.6K |
| Jan 2, 2025 | Jan 6, 2025 | Khara Rahul | Chief Legal Officer | Sell | 7.5 | -7,500 | -34.83% | ✓ | $470.7K |
| Dec 30, 2024 | Jan 2, 2025 | Quisel John D | CEO | Sell | 17.5 | -13,012 | -15.29% | ✓ | $806.1K |
| Dec 23, 2024 | Dec 26, 2024 | Quisel John D | CEO | Sell | 10.0 | -19,820 | -21.57% | ✓ | $1.3M |
| Dec 16, 2024 | Dec 18, 2024 | Quisel John D | CEO | Sell | 17.5 | -12,791 | -15.07% | ✓ | $844.3K |
| Dec 2, 2024 | Dec 4, 2024 | White William Richard | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $126.5K |
| Nov 25, 2024 | Nov 26, 2024 | Savage William Jacob | Chief Medical Officer | Sell | 7.5 | -14,183 | -25.98% | ✓ | $928.3K |
| Nov 15, 2024 | Nov 19, 2024 | Savage William Jacob | Chief Medical Officer | Sell | 17.5 | -9,158 | -18.48% | ✓ | $546.2K |
| Nov 1, 2024 | Nov 5, 2024 | White William Richard | Director | Sell | 7.5 | -7,337 | -57.27% | ✓ | $427.5K |
| Oct 1, 2024 | Oct 3, 2024 | White William Richard | Director | Sell | 13.8 | -201 | -100.00% | ✓ | $10.3K |
| Sep 16, 2024 | Sep 18, 2024 | Savage William Jacob | Chief Medical Officer | Sell | 37.5 | -1,500 | -3.58% | ✓ | $71.1K |
| Sep 3, 2024 | Sep 5, 2024 | White William Richard | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $97.2K |
| Sep 3, 2024 | Sep 4, 2024 | Savage William Jacob | Chief Medical Officer | Sell | 37.5 | -1,500 | -3.46% | ✓ | $75.9K |
| Aug 1, 2024 | Aug 5, 2024 | White William Richard | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $8.7K |
| Jul 8, 2024 | Jul 10, 2024 | Quisel John D | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2024 | Jul 3, 2024 | White William Richard | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $9.3K |
| Jun 17, 2024 | Jun 20, 2024 | Bitterman Kevin | Director | Buy | 100.0 | +222,223 | 112.05% | ✗ | $8M |
| Jun 17, 2024 | Jun 20, 2024 | Ashiya Mona | Director | Buy | 92.5 | +83,334 | 4.90% | ✗ | $3M |
| Jun 17, 2024 | Jun 20, 2024 | ORBIMED ADVISORS LLC | Director | Buy | 92.5 | +83,334 | 4.90% | ✗ | $3M |
| Jun 17, 2024 | Jun 20, 2024 | AI DMI LLC | 10% Owner | Neutral | 90.0 | +416,667 | 13.26% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | White William Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | Bitterman Kevin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | GEMAYEL GEORGES | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | Ratcliffe Liam | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | Chin Mark | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | Nicholson Donald William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2024 | Jun 14, 2024 | Ashiya Mona | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 3, 2024 | Jun 5, 2024 | White William Richard | Director | Sell | 10.0 | -1,957 | -100.00% | ✓ | $70.6K |
| May 1, 2024 | May 3, 2024 | White William Richard | Director | Sell | 15.0 | -201 | -100.00% | ✓ | $5.8K |